Last reviewed · How we verify
Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination. (PERISCOPEII)
A randomized controlled two-armed phase III trial for gastric cancer patients with peritoneal dissemination. Randomization between gastrectomy + cytoreductive surgery + HIPEC (experimental arm) and palliative systemic chemotherapy (standard arm).
Details
| Lead sponsor | The Netherlands Cancer Institute |
|---|---|
| Phase | PHASE3 |
| Status | ACTIVE_NOT_RECRUITING |
| Enrolment | 102 |
| Start date | Sun Oct 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Fri Oct 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Stomach Neoplasm
- Peritoneal Carcinomatosis
Interventions
- Cytoreductive surgery + Gastrecomy
- Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Countries
Netherlands